#29: Three Breakthroughs: Exciting News on Alzheimer’s, Warming Globe Problems and Solutions, and Smart Antibiotics

Dive into a captivating episode of the Alumni Ventures' Tech Optimist podcast as Mike Collins and Matt Caspari explore three breakthroughs that could redefine our health and environment. They kick off the discussion with the promising FDA approval of a new Alzheimer’s drug, offering hope in slowing the progression of this debilitating disease. Next, they tackle the pressing issue of global warming, discussing the record-breaking heat of summer 2023 and innovative solutions aimed at combating climate change. The episode concludes with a look at a revolutionary smart antibiotic that promises efficacy without compromising the microbiome, potentially transforming medical treatments. Join Mike and Matt as they delve into these technological advancements that hold the potential to dramatically improve our world.

To Learn More:

Speakers:

Chapters:
  • (00:00) - Intro
  • (02:04) - Exciting News on Alzheimer’s
  • (15:57) - Warming Globe Problems and Solutions
  • (25:01) - Smart Antibiotics
  • (29:41) - Closing



Legal Disclosure:

Creators and Guests

Mike Collins
Host
Mike Collins
CEO and Co-Founder at Alumni Ventures
David Carey
Producer
David Carey
Business Development at Alumni Ventures
Jeannie Masters
Producer
Jeannie Masters
SVP of Communication at Alumni Ventures
Keith Murphy
Producer
Keith Murphy
Director, Video Programs at Alumni Ventures
Matt Caspari
Guest
Matt Caspari
Managing Partner at Alumni Ventures' Deep Tech, Georgetown (Potomac Ventures) and UC Berkeley (Strawberry Creek Ventures) funds
Shail Highbloom
Producer
Shail Highbloom
Platform (CEO Services) at Alumni Ventures
#29: Three Breakthroughs: Exciting News on Alzheimer’s, Warming Globe Problems and Solutions, and Smart Antibiotics
Broadcast by